Colorectal Neoplasms clinical trials

Explore recruiting colorectal neoplasms clinical trials.

Recruiting colorectal neoplasms studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Colorectal Neoplasms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multicenter phase II study of preoperative chemoradiotherapy with CApecitabine plus Temozolomide in patients with MGMT silenced and microsatellite stable locally Advanced RecTal Cancer: the CATARTIC trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

AAS-Lynch - Assessment of the effect of a daily chemoprevention by aspirin low-dose of new or recurrent colorectal adenomas in patients with Lynch syndrome

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase III study in mCRC patients with RAS/BRAF wild type tissue and RAS/BRAF mutated in LIquid BIopsy to compare in first-line therapy FOLFIRI plus CetuxiMAb or BevacizumaB

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

France, Italy, Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors (FiREBOLT)

Germany, Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Colorectal Neoplasms trials by city

Colorectal Neoplasms in Toronto Colorectal Neoplasms in Vancouver Colorectal Neoplasms in Montreal Colorectal Neoplasms in Calgary Colorectal Neoplasms in Edmonton Colorectal Neoplasms in Ottawa Colorectal Neoplasms in Winnipeg Colorectal Neoplasms in Quebec City Colorectal Neoplasms in Hamilton Colorectal Neoplasms in Kitchener Colorectal Neoplasms in London Colorectal Neoplasms in Halifax Colorectal Neoplasms in New York Colorectal Neoplasms in Los Angeles Colorectal Neoplasms in Chicago Colorectal Neoplasms in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease